Alcohol Withdrawal Prevention: A Randomized Evaluation of Lorazepam and Ethanol--A Pilot Study
Open Access
- 1 September 2013
- journal article
- research article
- Published by AACN Publishing in American Journal of Critical Care
- Vol. 22 (5) , 398-406
Abstract
Background Alcohol withdrawal syndrome, characterized by confusion, agitation, and hallucinations, decreases the safety of patients with acute myocardial infarction. Unexpected hospitalization and sudden cessation of alcohol consumption may increase in-hospital complications and length of stay and even precipitate death. Purpose To perform a randomized evaluation of lorazepam and ethanol/lorazepam to evaluate the safety and efficacy of these 2 strategies for preventing alcohol withdrawal syndrome in patients with acute coronary syndromes. Methods Patients (n = 57) with myocardial infarction were screened for alcohol dependence by using the CAGE questionnaire and randomized to treatment with lorazepam or ethanol with lorazepam. Demographics and complication rates were analyzed by using χ2 tests (categorical variables) and t tests (continuous variables). Safety (composite complication rates) of the treatment strategy was evaluated by using the Fisher exact test, and length of stay by using the Wilcoxon rank-sum test. Results Safety-associated complication rates (self-extubation, delirium tremens, reinfarction) did not differ between groups (24% lorazepam vs 18% ethanol; P = .56). Days spent in the cardiac intensive care unit (7% lorazepam vs 2% ethanol; P = .32) and overall hospital stay (6% lorazepam vs 6% ethanol; P = .72) did not differ between the 2 groups. Conclusions These preliminary findings suggest that a randomized evaluation of treatment strategies to prevent complications associated with alcohol withdrawal in patients with acute myocardial infarction is safe and feasible.Keywords
This publication has 41 references indexed in Scilit:
- Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICUAnnals of Intensive Care, 2012
- Moderate ethanol ingestion and cardiovascular protection: From epidemiologic associations to cellular mechanismsJournal of Molecular and Cellular Cardiology, 2012
- Medications Acting on the GABA System in the Treatment of Alcoholic PatientsCurrent Pharmaceutical Design, 2010
- Analysis of the Factors Determining Survival of Alcoholic Withdrawal Syndrome Patients in a General HospitalAlcohol and Alcoholism, 2010
- Is alcohol beneficial or harmful for cardioprotection?Genes & Nutrition, 2009
- Alcohol Withdrawal Syndrome: Turning Minor Injuries Into a Major Problem2006
- Editor's CorrespondenceArchives of internal medicine (1960), 2005
- Management of Alcohol Withdrawal DeliriumAn Evidence-Based Practice GuidelineArchives of internal medicine (1960), 2004
- Caring for an alcohol-dependent patientNursing, 2002
- Screening for Alcohol Abuse Using CAGE Scores and Likelihood RatiosAnnals of Internal Medicine, 1991